2018 共识指南:血管生成检测的应用和解释

2018-05-15 国外心血管相关专家小组(统称) Angiogenesis. 2018 May 15.

新的血管的形成或生成是一个复杂的过程,并且在生长发育,组织气管在上以及多种疾病中起了重要的作用。血管再生经历了多个不连续的阶段,这些可以经过大量的生物检测进行评定和量化。本文主要描述了用于评估血管生成的体内、离体以及体外的生物检测方法,作为血管生成检测指南的第一版。

中文标题:

2018 共识指南:血管生成检测的应用和解释

英文标题:

Consensus guidelines for the use and interpretation of angiogenesis assays.

发布日期:

2018-05-15

简要介绍:

新的血管的形成或生成是一个复杂的过程,并且在生长发育,组织气管在上以及多种疾病中起了重要的作用。血管再生经历了多个不连续的阶段,这些可以经过大量的生物检测进行评定和量化。本文主要描述了用于评估血管生成的体内、离体以及体外的生物检测方法,作为血管生成检测指南的第一版。 

拓展指南:血管相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2018 共识指南:血管生成检测的应用和解释)] GetToolGuiderByIdResponse(projectId=1, id=cdc6a1c00159a4ec, title=2018 共识指南:血管生成检测的应用和解释, enTitle=Consensus guidelines for the use and interpretation of angiogenesis assays., guiderFrom=Angiogenesis. 2018 May 15., authorId=null, author=, summary=新的血管的形成或生成是一个复杂的过程,并且在生长发育,组织气管在上以及多种疾病中起了重要的作用。血管再生经历了多个不连续的阶段,这些可以经过大量的生物检测进行评定和量化。本文主要描述了用于评估血管生成的体内、离体以及体外的生物检测方法,作为血管生成检测指南的第一版。 , cover=, journalId=null, articlesId=null, associationId=738, associationName=国外心血管相关专家小组(统称), associationIntro=null, copyright=0, guiderPublishedTime=Tue May 15 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<div>新的血管的形成或生成是一个复杂的过程,并且在生长发育,组织气管在上以及多种疾病中起了重要的作用。血管再生经历了多个不连续的阶段,这些可以经过大量的生物检测进行评定和量化。本文主要描述了用于评估血管生成的体内、离体以及体外的生物检测方法,作为血管生成检测指南的第一版。 </div> <div><br> </div>拓展指南:<strong>与<font color=red>血管</font>相关指南:</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=1c5e91c00159a1d8" title="2018 多学科共识声明:急性缺血性卒中的血管内治疗(修订版)" target=_blank>2018 多学科共识声明:急性缺血性卒中的血管内治疗(修订版)</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=c5bd61c00159009a" title="2018 ACC/HRS/NASCI/SCAI/SCCT专家共识:心血管影像检查中优化应用电离辐射" target=_blank>2018 ACC/HRS/NASCI/SCAI/SCCT专家共识:心血管影像检查中优化应用电离辐射</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=72fe21c001589e61" title="2018 KSIN/KSS共识声明:减少再灌注时间的超急性血管内治疗流程" target=_blank>2018 KSIN/KSS共识声明:减少再灌注时间的超急性血管内治疗流程</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=08c801c00158853d" title="2018 ESVS临床实践指南:血管通路" target=_blank>2018 ESVS临床实践指南:血管通路</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=0100e1c00158810b" title="2018 临床实践指南:玻璃体内注射抗血管内皮生长因子药物治疗眼部血管疾病" target=_blank>2018 临床实践指南:玻璃体内注射抗血管内皮生长因子药物治疗眼部血管疾病</a></li> 更多信息请点击:<a href="http://www.medsci.cn/guideline/list.do?q=%E8%A1%80%E7%AE%A1" target=_blank>有关血管更多指南</a></ul>, tagList=[TagDto(tagId=75224, tagName=血管生成检测)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4611, appHits=129, showAppHits=0, pcHits=3769, showPcHits=1317, likes=155, shares=3, comments=3, approvalStatus=1, publishedTime=Mon May 21 22:17:22 CST 2018, publishedTimeString=2018-05-15, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Mon May 21 22:17:22 CST 2018, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 21:14:42 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2018 共识指南:血管生成检测的应用和解释)])
2018 共识指南:血管生成检测的应用和解释
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=318208, encodeId=09723182082f, content=受益学习了匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Thu May 24 20:07:51 CST 2018, time=2018-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=317733, encodeId=fd6e31e733ff, content=学习了谢谢分享!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Wed May 23 06:48:47 CST 2018, time=2018-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=317408, encodeId=637b31e408e2, content=好文献学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Tue May 22 07:05:12 CST 2018, time=2018-05-22, status=1, ipAttribution=)]
    2018-05-24 131****1460

    受益学习了匪浅

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=318208, encodeId=09723182082f, content=受益学习了匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Thu May 24 20:07:51 CST 2018, time=2018-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=317733, encodeId=fd6e31e733ff, content=学习了谢谢分享!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Wed May 23 06:48:47 CST 2018, time=2018-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=317408, encodeId=637b31e408e2, content=好文献学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Tue May 22 07:05:12 CST 2018, time=2018-05-22, status=1, ipAttribution=)]
    2018-05-23 大爰

    学习了谢谢分享!!

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=318208, encodeId=09723182082f, content=受益学习了匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Thu May 24 20:07:51 CST 2018, time=2018-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=317733, encodeId=fd6e31e733ff, content=学习了谢谢分享!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Wed May 23 06:48:47 CST 2018, time=2018-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=317408, encodeId=637b31e408e2, content=好文献学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Tue May 22 07:05:12 CST 2018, time=2018-05-22, status=1, ipAttribution=)]
    2018-05-22 张新亮1853311252142e2fm

    好文献学习了

    0